Marmet and Oxytocin Massage for Breast Milk Increase

What Was Tested

In this not phased trial, researchers set out to test Oxytocin.

The hypotheses of the study are as follows: H0.1.

It had three arms (groups): ARM1 (Marmet) (active comparator), ARM2 (Oxct.) (active comparator) and ARM3 (Plasebo) (placebo comparator).

A light touch will be applied to the women's wrists, elbows, and shoulders.

The registry classes the interventions as other.

More on the Plan

Specifically, the study investigates their effects on breast milk volume and maternal state anxiety levels during the early postpartum period.

Breast milk expression will be standardized using a hospital-grade electric pump, with a fixed pumping duration of 15 minutes per breast.

Milk volume will be measured using calibrated collection containers provided with the pump.

Vital signs (e.g., heart rate, blood pressure), self-reported pain levels (via Visual Analog Scale), and observed milk flow rate (rated as slow, moderate, or fast) will be recorded at each session.

Who Took Part

123 planned participants were the target.

It was open to women only aged from 18 years up to 35 years.

Healthy volunteers could join, not only people with the condition.

Examples of who could join: Aged between 18-35 years. Fluent in Turkish. Volunteering to participate in the study. Primiparous (first-time mothers). Within the first 2 hours postpartum (mothers performing their first breastfeeding under researcher supervision).

The full record lists 15 inclusion and 15 exclusion criteria; among the exclusions: are under 18 or over 35 years old; are multiparous (have given birth before); are encountered more than 2 hours postpartum.

How the Study Was Run

Design: randomized, parallel-group and single-blind.

The participants were allocated by chance, so the Oxytocin group and the comparison group should start out alike.

Groups ran in parallel: each of the participants stayed in one arm throughout.

In this single-blind Oxytocin study one party knew the assignments and the other did not.

Those kept unaware of assignments: participant.

It started in 2025-08-25 with completion listed for 2025-12-30.

It ran at 1 site in Turkey (Türkiye).

Its stated primary purpose is other.

What Was Measured

Primary outcome: Breast milk volume (time frame: up to 4 months).

It also tracked 1 secondary outcome, for example State Anxiety Scale Score.

What This Means in Plain Language

Put simply, this is a not phased, randomized trial of Oxytocin in 123 people.

It is still recruiting; no results are posted to the registry yet, so nothing here describes outcomes.

More context: the Oxytocin compound page, all human trials.